Neonatal Medicine

  • 제16권2호
  • /
  • Pages.172-181
  • /
  • 2009
  • /
  • 2287-9412(pISSN)
  • /
  • 2287-9803(eISSN)
대한신생아학회 (The Korean Society of Neonatology)
권호 표지

단일 신생아중환자실에서 경험한 10년간의 신생아 패혈증의 원인균 및 항생제 감수성 변화

Causative Agents and Antimicrobial Sensitivity of Neonatal Sepsis : Ten-year Experience in One Neonatal Intensive Care Unit

  • 박혜원 (울산대학교 의과대학 서울아산병원 소아청소년과) ;
  • 임진아 (울산대학교 의과대학 서울아산병원 소아청소년과) ;
  • 구소은 (울산대학교 의과대학 서울아산병원 소아청소년과) ;
  • 이병섭 (울산대학교 의과대학 서울아산병원 소아청소년과) ;
  • 김기수 (울산대학교 의과대학 서울아산병원 소아청소년과) ;
  • 피수영 (울산대학교 의과대학 서울아산병원 소아청소년과) ;
  • 김애란 (울산대학교 의과대학 서울아산병원 소아청소년과)
  • Park, Hye-Won (Department of Pediatrics, Division of Neonatology, University of Ulsan College of Medicine, childrens Hospital, Asan Medical Center) ;
  • Lim, Gin-A (Department of Pediatrics, Division of Neonatology, University of Ulsan College of Medicine, childrens Hospital, Asan Medical Center) ;
  • Koo, So-Eun (Department of Pediatrics, Division of Neonatology, University of Ulsan College of Medicine, childrens Hospital, Asan Medical Center) ;
  • Lee, Byong-Sop (Department of Pediatrics, Division of Neonatology, University of Ulsan College of Medicine, childrens Hospital, Asan Medical Center) ;
  • Kim, Ki-Soo (Department of Pediatrics, Division of Neonatology, University of Ulsan College of Medicine, childrens Hospital, Asan Medical Center) ;
  • Pi, Soo-Young (Department of Pediatrics, Division of Neonatology, University of Ulsan College of Medicine, childrens Hospital, Asan Medical Center) ;
  • Kim, Ai-Rhan (Department of Pediatrics, Division of Neonatology, University of Ulsan College of Medicine, childrens Hospital, Asan Medical Center)
  • 발행 : 2009.11.30

⟨ 이전 논문 다음 논문 ⟩

초록

목 적 : 신생아 사망 및 이환의주요 원인인 패혈증의 치료에 있어서 적절한 항생제의 선택은 항생제 내성을 줄이고 다약제 내성 균주의 출현을 방지할 수 있다. 이제 저자들은 단일 신생아중환자실에서 경험한 신생아 패혈증 빈도와 원인균 및 항생제 감수성 변화를 지난 10년간에 걸쳐 조사하였다. 방 법 : 1998년 1월부터 2007년 12월까지 본원 신생아 중환자실에 입원한 환아 중 혈액 배양 검사상 균이 동정되었던 환아들을 대상으로 의무기록을 통해 1998년부터 2002년까지를 전반기, 2003년부터 2007년까지를 후반기로 구분하여 각 발생 시기에 따른 패혈증의 원인균과 항생제 감수성을 후향적으로 분석하였다. 결 과 : 315명의 환아가 총 350례의 패혈증을 경험하였으며, 조기 패혈증의 원인균으로는 전반기는 S. epidermidis, S.aureus, P. aeruginosa, Enterobacter cloacae, 후반기에는 S. epidermidis, E. cloacae가 흔하게 검출되었다. 후기 패혈증의 경우는 전반기에는 coagulase negative S. epidermidis, S. aureus, K. pneumoniae가 전반기와 후반기 모두에서 가장 흔하게 배양되었다. 다약제 내성균에 의한 패혈증은 엄격한 감염관리를 시행한 이후 감소하는 경향을 보였다. 그람 양성균의 경우 penicillin, ampicillin, 그리고 cefotaxime에 대해 전후반기 모두에서 0-20%의 낮은 감수성을 보였다. 그람 음성균의 경우는 Enterobacter spp의 amikacin에 대한 감수성이 전반기(15.8%)에 비해 후반기(37.5%)에 증가하는 양상이었다. P. aeruginosa는 amikacin에 대해 전반기 33.3%에서 후반기 20%로 감수성이 감소하였다. P. aeruginosa를 제외한 그람 음성균은 cefotaxime에 대해 50-60% 정도의 항생제 감수성을 보였다. P. aeruginosa를 제외한 그람 음성균의 경우 imipenem과 ciprofloxacin에 대해 80% 이상의 감수성을 보였다. 결 론 : 지난 10년간의 신생아 패혈증의 원인균과 항생제 감수성의 변화양상을 확인하였으며, 이는 경험적 항생제 사용을 선택하는데 도움이 될 것으로 생각된다. 전반기에 비해 후반기에는 엄격한 감염관리를 통해 다약제 내성균에 의한 패혈증 및 전체 신생아 패혈증의 발생이 현저히 감소하였다. 따라서 신생아 패혈증의 발생과 감염에 의한 사망을 줄이기 위해서는 적절한 항생제 선택과 더불어 지속적인 감염관리가 필요할 것으로 사료된다.

Purpose: To identify trends in causative bacterial organisms for neonatal sepsis and antimicrobial susceptibilities over 10 years in one neonatal intensive care unit. Methods: We retrospectively reviewed the cases of culture-proven neonatal sepsis between January 1998 and December 2007. The 10-year period was divided into two phases (phase I, 1998-2002; phase II, 2003-2007) to distinguish the differences during the entire period. Results: Total 350 episodes of neonatal sepsis were identified in 315 neonates. The common pathogens of early-onset sepsis were S. epidermidis, S. aureus, P. aeruginosa, and E. cloacae in phase I, and S. epidermidis and E. cloacae in phase II. In cases of late-onset sepsis, coagulase negative Staphylococcus, S. aureus, and K. pneumoniae were isolated frequently in both phases. The incidence of sepsis caused by multi-drug resistant organisms decreased with strict infection control. Gram positive organisms showed 0-20% susceptibility to penicillin, ampicillin, and cefotaxime in both phases. Sensitivity to amikacin for Enterobacter spp. increased, whereas P. aeruginosa showed decreased sensitivity in phase II. Between 50% and 60% of other gram negative bacteria, except P. aeruginosa, were susceptible to cefotaxime in phase II in contrast to phase I. Greater than 80% of gram negative bacteria were sensitive to imipenem except P. aeruginosa and ciprofloxacin in both phases. Conclusion: The trend in causative microorganisms and antimicrobial susceptibilities can be used as a guideline for selection of appropriate antibiotics. A particular attention should be paid to infection control, especially to reduce sepsis caused by multi-drug resistant organisms.

키워드

참고문헌

  1. Hudome SM, Fisher MC. Nosocomial infections in the neonatal intensive care unit. Curr Opin Infect Dis 2001;14:303-7. https://doi.org/10.1097/00001432-200106000-00010
  2. Kwon HJ, Kim SY, Cho CY, Choi YY, Shin JH, Suh SP. Nosocomial infection in neonatal intensive care unit. J Korean Pediatr Soc 2002;45:719-26.
  3. Polin RA. The "ins and outs" of neonatal sepsis. J Pediatr 2003;143:3-4. https://doi.org/10.1016/S0022-3476(03)00271-3
  4. Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 2003;27:293-301. https://doi.org/10.1016/S0146-0005(03)00046-6
  5. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998;17:593-8. https://doi.org/10.1097/00006454-199807000-00004
  6. Agnihotri N, Kaistha N, Gupta V. Antimicrobial susceptibility of isolates from neonatal septicemia. Jpn J Infect Dis 2004;57:273-5.
  7. Gotoff SP, Behrman RE. Neonatal septicemia. J Pediatr 1970;76:142-53. https://doi.org/10.1016/S0022-3476(70)80148-2
  8. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005;116:595-602. https://doi.org/10.1542/peds.2005-0552
  9. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004;51:939-59. https://doi.org/10.1016/j.pcl.2004.03.009
  10. Sankar MJ, Agarwal R, Deorari AK, Paul VK. Sepsis in the newborn. Indian J Pediatr 2008;75:261-6. https://doi.org/10.1007/s12098-008-0056-z
  11. Yalaz M, Cetin H, Akisu M, Aydemir S, Tunger A, Kultursay N. Neonatal nosocomial sepsis in a level-III NICU: evaluation of the causative agents and antimicrobial susceptibilities. Turk J Pediatr 2006;48:13-8.
  12. Kliegman RM, Behrman RE, Jenson HB, Stanton BF, Nelson WE. Infections of the neonatal infant. In: Stoll BJ, editor. Nelson textbook of pediatrics. 18rd ed. Philadelphia: WB Saunders, 2007:794-811.
  13. Kim KA, Shin SM, Choi JH. A Nationwide survey on the causative organisms of neonatal sepsis in Korea. J Korean Pediatr Soc 2002;45:55-63.
  14. Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2006;91:F208-12. https://doi.org/10.1136/adc.2004.064188
  15. Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002;110:690-5. https://doi.org/10.1542/peds.110.4.690
  16. Sung JS, Kim DY, Kim SH, Byun HS, Hwang TJ, Choi YY. Analysis of causative microorganisms and choice of antibiotics according to the onset of neonatal sepsis. Korean J Pediatr 2006;49:623-9. https://doi.org/10.3345/kjp.2006.49.6.623
  17. Klingenberg C, Aarag E, Ronnestad A, Sollid JE, Abrahamsen TG, Kjeldsen G, et al. Coagulase-negative staphylococcal sepsis in neonates. Association between antibiotic resistance, biofilm formation and the host inflammatory response. Pediatr Infect Dis J 2005;24:817-22. https://doi.org/10.1097/01.inf.0000176735.20008.cd
  18. Horbar JD, Carpenter JH, Buzas J, Soll RF, Suresh G, Bracken MB, et al. Collaborative quality improvement to promote evidence based surfactant for preterm infants: a cluster randomised trial. BMJ 2004;329:1004. https://doi.org/10.1136/bmj.329.7473.1004
  19. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:72-80. https://doi.org/10.1016/S0022-3476(96)70192-0
  20. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:63-71. https://doi.org/10.1016/S0022-3476(96)70191-9
  21. Washburn TC, Medearis DN, Jr., Childs B. Sex differences in susceptibility to infections. Pediatrics 1965;35:57-64.
  22. Strunk T, Richmond P, Simmer K, Currie A, Levy O, Burgner D. Neonatal immune responses to coagulase-negative staphylococci. Curr Opin Infect Dis 2007;20:370-5. https://doi.org/10.1097/QCO.0b013e3281a7ec98
  23. Su BH, Hsieh HY, Chiu HY, Lin HC. Nosocomial infection in a neonatal intensive care unit: a prospective study in Taiwan. Am J Infect Control 2007;35:190-5. https://doi.org/10.1016/j.ajic.2006.07.004
  24. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediaatrics 2002;110:285-91. https://doi.org/10.1542/peds.110.2.285
  25. Graham PL. Staphylococcal and enterococcal infections in the neonatal intensive care unit. Semin Perinatol 2002;26:322-31. https://doi.org/10.1053/sper.2002.36265
  26. Hira V, Sluijter M, Estevao S, Horst-Kreft D, Ott A, de Groot R, et al. Clinical and molecular epidemiologic characteristics of coagulase-negative staphylococcal bloodstream infections in intensive care neonates. Pediatr Infect Dis J 2007;26:607-12. https://doi.org/10.1097/INF.0b013e318060cc03
  27. Kim MW, Jang HO, Chang DY, Cho JR, Kim YA, Choi HM, et al. Group B streptococcal colonization rate in korean pregnant women. Korean J Obstet Gynecol 2006;49:337-44.
  28. Huang SY, Tang RB, Chen SJ, Chung RL. Coagulase-negative staphylococcal bacteremia in critically ill children: risk factors and antimicrobial susceptibility. J Microbiol Immunol Infect 2003;36:51-5.
  29. Hershow RC, Khayr WF, Smith NL. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol 1992;13:587-93. https://doi.org/10.1086/646433
  30. Harbarth S, Rutschmann O, Sudre P, Pittet D. Immpact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998;158:182-9. https://doi.org/10.1001/archinte.158.2.182
  31. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-9. https://doi.org/10.1086/345476